TY - JOUR AU - Hoos, A. PY - 2016 DA - 2016// TI - Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations JO - Nat Rev Drug Discov VL - 15 UR - https://doi.org/10.1038/nrd.2015.35 DO - 10.1038/nrd.2015.35 ID - Hoos2016 ER - TY - JOUR AU - Farber, S. H. AU - Tsvankin, V. AU - Narloch, J. L. AU - Kim, G. J. AU - Salama, A. K. AU - Vlahovic, G. PY - 2016 DA - 2016// TI - Embracing rejection: immunologic trends in brain metastasis JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1172153 DO - 10.1080/2162402X.2016.1172153 ID - Farber2016 ER - TY - JOUR AU - Batich, K. A. AU - Reap, E. A. AU - Archer, G. E. AU - Sanchez-Perez, L. AU - Nair, S. K. AU - Schmittling, R. J. PY - 2017 DA - 2017// TI - Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-2057 DO - 10.1158/1078-0432.CCR-16-2057 ID - Batich2017 ER - TY - JOUR AU - Reardon, D. A. AU - Gokhale, P. C. AU - Klein, S. R. AU - Ligon, K. L. AU - Rodig, S. J. AU - Ramkissoon, S. H. PY - 2016 DA - 2016// TI - Glioblastoma eradication following immune checkpoint blockade in an Orthotopic JO - Immunocompetent Model Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0151 DO - 10.1158/2326-6066.CIR-15-0151 ID - Reardon2016 ER - TY - JOUR AU - Fecci, P. E. AU - Ochiai, H. AU - Mitchell, D. A. AU - Grossi, P. M. AU - Sweeney, A. E. AU - Archer, G. E. PY - 2007 DA - 2007// TI - Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2070 DO - 10.1158/1078-0432.CCR-06-2070 ID - Fecci2007 ER - TY - JOUR AU - Larkin, J. AU - Hodi, F. S. AU - Wolchok, J. D. PY - 2015 DA - 2015// TI - Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMc1509660 DO - 10.1056/NEJMc1509660 ID - Larkin2015 ER - TY - JOUR AU - Weber, J. S. AU - Kahler, K. C. AU - Hauschild, A. PY - 2012 DA - 2012// TI - Management of immune-related adverse events and kinetics of response with ipilimumab JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.41.6750 DO - 10.1200/JCO.2012.41.6750 ID - Weber2012 ER - TY - JOUR AU - Michot, J. M. AU - Bigenwald, C. AU - Champiat, S. AU - Collins, M. AU - Carbonnel, F. AU - Postel-Vinay, S. PY - 2016 DA - 2016// TI - Immune-related adverse events with immune checkpoint blockade: a comprehensive review JO - Eur J Cancer VL - 54 UR - https://doi.org/10.1016/j.ejca.2015.11.016 DO - 10.1016/j.ejca.2015.11.016 ID - Michot2016 ER - TY - JOUR AU - Garant, A. AU - Guilbault, C. AU - Ekmekjian, T. AU - Greenwald, Z. AU - Murgoi, P. AU - Vuong, T. PY - 2017 DA - 2017// TI - Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: a systematic review JO - Crit Rev Oncol Hematol VL - 120 UR - https://doi.org/10.1016/j.critrevonc.2017.10.009 DO - 10.1016/j.critrevonc.2017.10.009 ID - Garant2017 ER - TY - JOUR AU - Margolin, K. AU - Ernstoff, M. S. AU - Hamid, O. AU - Lawrence, D. AU - McDermott, D. AU - Puzanov, I. PY - 2012 DA - 2012// TI - Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70090-6 DO - 10.1016/S1470-2045(12)70090-6 ID - Margolin2012 ER - TY - JOUR AU - Queirolo, P. AU - Spagnolo, F. AU - Ascierto, P. A. AU - Simeone, E. AU - Marchetti, P. AU - Scoppola, A. PY - 2014 DA - 2014// TI - Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases JO - J Neuro-Oncol VL - 118 UR - https://doi.org/10.1007/s11060-014-1400-y. DO - 10.1007/s11060-014-1400-y. ID - Queirolo2014 ER - TY - JOUR AU - Parakh, S. AU - Park, J. J. AU - Mendis, S. AU - Rai, R. AU - Xu, W. AU - Lo, S. PY - 2017 DA - 2017// TI - Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases JO - Br J Cancer VL - 116 UR - https://doi.org/10.1038/bjc.2017.142 DO - 10.1038/bjc.2017.142 ID - Parakh2017 ER - TY - JOUR AU - Horvat, T. Z. AU - Adel, N. G. AU - Momtaz, P. AU - Postow, M. A. AU - Callahan, M. K. PY - 2015 DA - 2015// TI - Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with Ipilimumab at memorial Sloan Kettering Cancer center JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.60.8448 DO - 10.1200/JCO.2015.60.8448 ID - Horvat2015 ER - TY - JOUR AU - Attia, P. AU - Phan, G. Q. AU - Maker, A. V. AU - Robinson, M. R. AU - Quezado, M. M. AU - Yang, J. C. PY - 2005 DA - 2005// TI - Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.205 DO - 10.1200/JCO.2005.06.205 ID - Attia2005 ER - TY - JOUR AU - Phan, G. Q. AU - Yang, J. C. AU - Sherry, R. M. AU - Hwu, P. AU - Topalian, S. L. AU - Schwartzentruber, D. J. PY - 2003 DA - 2003// TI - Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1533209100 DO - 10.1073/pnas.1533209100 ID - Phan2003 ER - TY - JOUR AU - Harmankaya, K. AU - Erasim, C. AU - Koelblinger, C. AU - Ibrahim, R. AU - Hoos, A. AU - Pehamberger, H. PY - 2011 DA - 2011// TI - Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy JO - Med Oncol VL - 28 UR - https://doi.org/10.1007/s12032-010-9606-0 DO - 10.1007/s12032-010-9606-0 ID - Harmankaya2011 ER - TY - JOUR AU - Beck, K. E. AU - Blansfield, J. A. AU - Tran, K. Q. AU - Feldman, A. L. AU - Hughes, M. S. AU - Royal, R. E. PY - 2006 DA - 2006// TI - Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.5716 DO - 10.1200/JCO.2005.04.5716 ID - Beck2006 ER - TY - JOUR AU - Downey, S. G. AU - Klapper, J. A. AU - Smith, F. O. AU - Yang, J. C. AU - Sherry, R. M. AU - Royal, R. E. PY - 2007 DA - 2007// TI - Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0187 DO - 10.1158/1078-0432.CCR-07-0187 ID - Downey2007 ER - TY - JOUR AU - Marchetti, M. C. AU - Di Marco, B. AU - Cifone, G. AU - Migliorati, G. AU - Riccardi, C. PY - 2003 DA - 2003// TI - Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-06-1779 DO - 10.1182/blood-2002-06-1779 ID - Marchetti2003 ER - TY - JOUR AU - Mitchell, C. D. AU - Richards, S. M. AU - Kinsey, S. E. AU - Lilleyman, J. AU - Vora, A. AU - Eden, T. O. PY - 2005 DA - 2005// TI - Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial JO - Br J Haematol VL - 129 UR - https://doi.org/10.1111/j.1365-2141.2005.05509.x DO - 10.1111/j.1365-2141.2005.05509.x ID - Mitchell2005 ER - TY - JOUR AU - Bianchi, M. AU - Meng, C. AU - Ivashkiv, L. B. PY - 2000 DA - 2000// TI - Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.160099797 DO - 10.1073/pnas.160099797 ID - Bianchi2000 ER - TY - JOUR AU - Franchimont, D. AU - Galon, J. AU - Vacchio, M. S. AU - Fan, S. AU - Visconti, R. AU - Frucht, D. M. PY - 2002 DA - 2002// TI - Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha JO - J Immunol VL - 168 UR - https://doi.org/10.4049/jimmunol.168.5.2212 DO - 10.4049/jimmunol.168.5.2212 ID - Franchimont2002 ER - TY - JOUR AU - Mitchell, D. A. AU - Xie, W. AU - Schmittling, R. AU - Learn, C. AU - Friedman, A. AU - McLendon, R. E. PY - 2008 DA - 2008// TI - Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma JO - Neuro-Oncology VL - 10 UR - https://doi.org/10.1215/15228517-2007-035 DO - 10.1215/15228517-2007-035 ID - Mitchell2008 ER - TY - JOUR AU - Scheurer, M. E. AU - Bondy, M. L. AU - Aldape, K. D. AU - Albrecht, T. AU - El-Zein, R. PY - 2008 DA - 2008// TI - Detection of human cytomegalovirus in different histological types of gliomas JO - Acta Neuropathol VL - 116 UR - https://doi.org/10.1007/s00401-008-0359-1 DO - 10.1007/s00401-008-0359-1 ID - Scheurer2008 ER - TY - JOUR AU - Crough, T. AU - Beagley, L. AU - Smith, C. AU - Jones, L. AU - Walker, D. G. AU - Khanna, R. PY - 2012 DA - 2012// TI - Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme JO - Immunol Cell Biol VL - 90 UR - https://doi.org/10.1038/icb.2012.19 DO - 10.1038/icb.2012.19 ID - Crough2012 ER - TY - JOUR AU - Berghoff, A. S. AU - Fuchs, E. AU - Ricken, G. AU - Mlecnik, B. AU - Bindea, G. AU - Spanberger, T. PY - 2016 DA - 2016// TI - Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2015.1057388 DO - 10.1080/2162402X.2015.1057388 ID - Berghoff2016 ER - TY - JOUR AU - Broeren, C. P. AU - Gray, G. S. AU - Carreno, B. M. AU - June, C. H. PY - 2000 DA - 2000// TI - Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile JO - J Immunol VL - 165 UR - https://doi.org/10.4049/jimmunol.165.12.6908 DO - 10.4049/jimmunol.165.12.6908 ID - Broeren2000 ER - TY - JOUR AU - Lanier, L. L. AU - O'Fallon, S. AU - Somoza, C. AU - Phillips, J. H. AU - Linsley, P. S. AU - Okumura, K. PY - 1995 DA - 1995// TI - CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL JO - J Immunol VL - 154 ID - Lanier1995 ER - TY - JOUR AU - Roederer, M. PY - 2011 DA - 2011// TI - Interpretation of cellular proliferation data: avoid the panglossian JO - Cytometry A VL - 79 UR - https://doi.org/10.1002/cyto.a.21010 DO - 10.1002/cyto.a.21010 ID - Roederer2011 ER - TY - JOUR AU - Zacharchuk, C. M. AU - Mercep, M. AU - Chakraborti, P. K. AU - Simons, S. S. AU - Ashwell, J. D. PY - 1990 DA - 1990// TI - Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic JO - J Immunol VL - 145 ID - Zacharchuk1990 ER - TY - JOUR AU - Linsley, P. S. AU - Nadler, S. G. AU - Bajorath, J. AU - Peach, R. AU - Leung, H. T. AU - Rogers, J. PY - 1995 DA - 1995// TI - Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.25.15417 DO - 10.1074/jbc.270.25.15417 ID - Linsley1995 ER - TY - JOUR AU - van der Merwe, P. A. AU - Bodian, D. L. AU - Daenke, S. AU - Linsley, P. AU - Davis, S. J. PY - 1997 DA - 1997// TI - CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics JO - J Exp Med VL - 185 UR - https://doi.org/10.1084/jem.185.3.393 DO - 10.1084/jem.185.3.393 ID - van der Merwe1997 ER - TY - JOUR AU - Walker, L. S. AU - Sansom, D. M. PY - 2011 DA - 2011// TI - The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses JO - Nat Rev Immunol VL - 11 UR - https://doi.org/10.1038/nri3108 DO - 10.1038/nri3108 ID - Walker2011 ER - TY - JOUR AU - Engelhardt, J. J. AU - Sullivan, T. J. AU - Allison, J. P. PY - 2006 DA - 2006// TI - CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism JO - J Immunol VL - 177 UR - https://doi.org/10.4049/jimmunol.177.2.1052 DO - 10.4049/jimmunol.177.2.1052 ID - Engelhardt2006 ER - TY - JOUR AU - Qureshi, O. S. AU - Zheng, Y. AU - Nakamura, K. AU - Attridge, K. AU - Manzotti, C. AU - Schmidt, E. M. PY - 2011 DA - 2011// TI - Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 JO - Science VL - 332 UR - https://doi.org/10.1126/science.1202947 DO - 10.1126/science.1202947 ID - Qureshi2011 ER - TY - STD TI - Woroniecka K, Chongsathidkiet P, Rhodin KE, Kemeny HR, Dechant CA, Farber SH, et al. T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma. Clin Cancer Res. 2018; https://doi.org/10.1158/1078-0432.CCR-17-1846. ID - ref36 ER - TY - JOUR AU - Kaal, E. C. AU - Vecht, C. J. PY - 2004 DA - 2004// TI - The management of brain edema in brain tumors JO - Curr Opin Oncol VL - 16 UR - https://doi.org/10.1097/01.cco.0000142076.52721.b3 DO - 10.1097/01.cco.0000142076.52721.b3 ID - Kaal2004 ER - TY - JOUR AU - Min, L. AU - Hodi, F. S. AU - Kaiser, U. B. PY - 2015 DA - 2015// TI - Corticosteroids and immune checkpoint blockade JO - Aging (Albany NY) VL - 7 UR - https://doi.org/10.18632/aging.100797 DO - 10.18632/aging.100797 ID - Min2015 ER - TY - STD TI - Gulley JL, Madan RA, Pachynski R, Mulders P, Sheikh NA, Trager J, et al. Role of antigen spread and distinctive characteristics of immunotherapy in Cancer treatment. J Natl Cancer Inst. 2017;109(4) https://doi.org/10.1093/jnci/djw261. ID - ref39 ER - TY - JOUR AU - Greenwald, R. J. AU - Boussiotis, V. A. AU - Lorsbach, R. B. AU - Abbas, A. K. AU - Sharpe, A. H. PY - 2001 DA - 2001// TI - CTLA-4 regulates induction of anergy in vivo JO - Immunity VL - 14 UR - https://doi.org/10.1016/S1074-7613(01)00097-8 DO - 10.1016/S1074-7613(01)00097-8 ID - Greenwald2001 ER - TY - JOUR AU - Xia, M. AU - Gasser, J. AU - Feige, U. PY - 1999 DA - 1999// TI - Dexamethasone enhances CTLA-4 expression during T cell activation JO - Cell Mol Life Sci VL - 55 UR - https://doi.org/10.1007/s000180050403 DO - 10.1007/s000180050403 ID - Xia1999 ER - TY - STD TI - Xing K, Gu B, Zhang P, Wu X. Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy. BMC Immunol. 2015;16(39) https://doi.org/10.1186/s12865-015-0103-2. ID - ref42 ER - TY - JOUR AU - Hinrichs, C. S. AU - Palmer, D. C. AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2005 DA - 2005// TI - Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells JO - J Immunother VL - 28 UR - https://doi.org/10.1097/01.cji.0000177999.95831.7b DO - 10.1097/01.cji.0000177999.95831.7b ID - Hinrichs2005 ER - TY - JOUR AU - Schartz, N. E. AU - Farges, C. AU - Madelaine, I. AU - Bruzzoni, H. AU - Calvo, F. AU - Hoos, A. PY - 2010 DA - 2010// TI - Complete regression of a previously untreated melanoma brain metastasis with ipilimumab JO - Melanoma Res VL - 20 UR - https://doi.org/10.1097/CMR.0b013e3283364a37. DO - 10.1097/CMR.0b013e3283364a37. ID - Schartz2010 ER - TY - JOUR AU - Weber, J. S. AU - Hodi, F. S. AU - Wolchok, J. D. AU - Topalian, S. L. AU - Schadendorf, D. AU - Larkin, J. PY - 2017 DA - 2017// TI - Safety profile of Nivolumab monotherapy: a pooled analysis of patients with advanced melanoma JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2015.66.1389 DO - 10.1200/JCO.2015.66.1389 ID - Weber2017 ER - TY - JOUR AU - Jelsma, R. AU - Bucy, P. C. PY - 1967 DA - 1967// TI - The treatment of glioblastoma multiforme of the brain JO - J Neurosurg VL - 27 UR - https://doi.org/10.3171/jns.1967.27.5.0388 DO - 10.3171/jns.1967.27.5.0388 ID - Jelsma1967 ER - TY - JOUR AU - Hodi, F. S. AU - Lawrence, D. AU - Lezcano, C. AU - Wu, X. AU - Zhou, J. AU - Sasada, T. PY - 2014 DA - 2014// TI - Bevacizumab plus ipilimumab in patients with metastatic melanoma JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0053 DO - 10.1158/2326-6066.CIR-14-0053 ID - Hodi2014 ER -